Establishment and in-depth characterization of a genetically engineered mouse model of metastatic colorectal cancer

被引:0
|
作者
Schoelch, Sebastian [1 ]
Blickensdorfer, Linda [2 ]
Weichert, Wilko [2 ]
Muders, Michael [1 ]
Weitz, Juergen [1 ]
Koch, Moritz [1 ]
机构
[1] Univ Hosp Carl Gustav Carus, Dresden, Germany
[2] Univ Heidelberg Hosp, Heidelberg, Germany
关键词
D O I
10.1158/1538-7445.AM2014-67
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
67
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Genetically engineered mouse models for hereditary cancer syndromes
    Biswas, Kajal
    Mohammed, Altaf
    Sharan, Shyam K.
    Shoemaker, Robert H.
    CANCER SCIENCE, 2023, 114 (05) : 1800 - 1815
  • [42] Genetically engineered mouse models of human breast cancer
    RA Jensen
    Breast Cancer Research, 5 (Suppl 1)
  • [43] A novel genetically engineered mouse model of ovarian carcinosarcoma
    Bangiev-Girsh, Einav
    Basis, Amir
    Zannou, Paul
    Naroditsky, Inna
    Aizic, Asaf
    Aronheim, Ami
    Berger, Liron
    Perets, Ruth
    CANCER RESEARCH, 2024, 84 (05)
  • [44] In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery
    Di Sapia, Rossella
    Moro, Federico
    Montanarella, Marica
    Iori, Valentina
    Micotti, Edoardo
    Tolomeo, Daniele
    Wang, Kevin K. W.
    Vezzani, Annamaria
    Ravizza, Teresa
    Zanier, Elisa R.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)
  • [45] Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study
    Prieto, Veronica
    Ludwig, Johannes M.
    Farris, Alton B.
    Nagaraju, Ganji Purnachandra
    Lawal, Taoreed O.
    El-Rayes, Bassel
    Kim, Hyun S.
    PLOS ONE, 2017, 12 (05):
  • [46] In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery
    Rossella Di Sapia
    Federico Moro
    Marica Montanarella
    Valentina Iori
    Edoardo Micotti
    Daniele Tolomeo
    Kevin K. W. Wang
    Annamaria Vezzani
    Teresa Ravizza
    Elisa R. Zanier
    Acta Neuropathologica Communications, 9
  • [47] The mighty mouse: genetically engineered mouse models in cancer drug development
    Norman E. Sharpless
    Ronald A. DePinho
    Nature Reviews Drug Discovery, 2006, 5 : 741 - 754
  • [48] Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
    Yip-Schneider, Michele T.
    Wu, Huangbing
    Stantz, Keith
    Agaram, Narasimhan
    Crooks, Peter A.
    Schmidt, C. Max
    BMC CANCER, 2013, 13
  • [49] Preclinical molecular targeting therapy of pancreatic cancer using a genetically engineered mouse model
    Miyabayashi, Koji
    Ijichi, Hideaki
    Mohri, Dal
    Tada, Motohisa
    Asaoka, Yoshinari
    Ikenoue, Tsuneo
    Omata, Masao
    Moses, Harold L.
    Koike, Kazuhiko
    CANCER RESEARCH, 2011, 71
  • [50] A genetically engineered mouse model to study oncofetal CRIPTO in aggressive lethal prostate cancer
    Rodrigues Sousa, E.
    Zoni, E.
    De Menna, M.
    Thalmann, G.
    Kruithof-De Julio, M.
    EUROPEAN UROLOGY, 2022, 81 : S631 - S631